TrialJournal for immunotherapy of cancer2024

Preliminary efficacy and safety of YSCH-01 in patients with advanced solid tumors: an investigator-initiated trial.

Yandong He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.